13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q3 2023 · Filed August 11, 2023 · Accession 0001104659-23-090482
Total Value
$803.6M
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Disc Medicine, Inc. | IRON | 3,461,784 | $153.7M | 19.13% |
| 2 | Kymera Therapeutics, Inc. | KYMR | 5,858,262 | $134.7M | 16.76% |
| 3 | Dyne Therapeutics, Inc. | DYN | 9,885,449 | $111.2M | 13.84% |
| 4 | Day One Biopharmaceuticals, Inc. | DAWN | 7,608,394 | $90.8M | 11.31% |
| 5 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $54.9M | 6.83% |
| 6 | Third Harmonic Bio, Inc. | 88427A107 | 10,907,859 | $52.5M | 6.53% |
| 7 | Replimune Group, Inc. | REPL | 2,098,300 | $48.7M | 6.06% |
| 8 | Generation Bio, Co. | 37148K100 | 8,279,484 | $45.5M | 5.67% |
| 9 | Aerovate Therapeutics, Inc. | 008064107 | 2,039,249 | $35.0M | 4.35% |
| 10 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $32.9M | 4.10% |
| 11 | Akero Therapeutics, Inc. | 00973Y108 | 594,251 | $27.7M | 3.45% |
| 12 | Xilio Therapeutics, Inc. | XLO | 2,759,344 | $7.2M | 0.90% |
| 13 | AvroBio, Inc. | 05455M100 | 4,541,381 | $4.3M | 0.54% |
| 14 | Magenta Therapeutics, Inc. | 55910K108 | 3,791,698 | $2.9M | 0.36% |
| 15 | Spero Therapeutics, Inc. | SPRO | 1,013,438 | $1.5M | 0.18% |